FdaApplication
NDA 202806
Identifiers
- fda_app_no: NDA202806
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2013-05-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAFINLAR | DABRAFENIB MESYLATE | EQ 50MG BASE | CAPSULE;ORAL |
| TAFINLAR | DABRAFENIB MESYLATE | EQ 75MG BASE | CAPSULE;ORAL |
2 products